SubMagna was initially developed as an alternative dosing form for commercially available semaglutide† and tirzepatide† in nonsterile compounded preparations. However, it also accommodates a broad range of active pharmaceutical ingredients (APIs), including, but not limited to, progesterone, testosterone, sildenafil, tadalafil, oxytocin and melatonin.

Read More